Cargando…

Classical and Next-Generation Vaccine Platforms to SARS-CoV-2: Biotechnological Strategies and Genomic Variants

Several coronaviruses (CoVs) have been identified as human pathogens, including the α-CoVs strains HCoV-229E and HCoV-NL63 and the β-CoVs strains HCoV-HKU1 and HCoV-OC43. SARS-CoV, MERS-CoV, and SARS-CoV-2 are also classified as β-coronavirus. New SARS-CoV-2 spike genomic variants are responsible fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Simões, Rachel Siqueira de Queiroz, Rodríguez-Lázaro, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877900/ https://www.ncbi.nlm.nih.gov/pubmed/35206580 http://dx.doi.org/10.3390/ijerph19042392

Ejemplares similares

Platforms for Production of Protein-Based Vaccines: From Classical to Next-Generation Strategies
por: Cid, Raquel, et al.
Publicado: (2021)

Development of Next Generation Vaccines against SARS-CoV-2 and Variants of Concern
por: Al-Fattah Yahaya, Abdul Aziz, et al.
Publicado: (2023)

A Two-Dimensional Pooling Strategy for Rare Variant Detection on Next-Generation Sequencing Platforms
por: Zuzarte, Philip C., et al.
Publicado: (2014)

Big data and computational advancements for next generation of Microbial Biotechnology
por: Udaondo, Zulema
Publicado: (2021)

RNAi to treat SARS‐CoV‐2—variant proofing the next generation of therapies
por: McMillan, Nigel A J, et al.
Publicado: (2022)

A multiplexed, next generation sequencing platform for high-throughput detection of SARS-CoV-2
por: Aynaud, Marie-Ming, et al.
Publicado: (2021)

Editorial: Probiogenomics of classic and next-generation probiotics
por: Carvalho, Rodrigo D. O., et al.
Publicado: (2022)

Sequencing of BAC pools by different next generation sequencing platforms and strategies
por: Taudien, Stefan, et al.
Publicado: (2011)

Development of nano- and microdevices for the next generation of biotechnology, wearables and miniaturized instrumentation
por: Gomez Palacios, Luna R., et al.
Publicado: (2022)

Identification of SARS-CoV-2 Variants of Concern Using Amplicon Next-Generation Sequencing
por: Nasereddin, Abdelmajeed, et al.
Publicado: (2022)

Next-generation nanophotonic-enabled biosensors for intelligent diagnosis of SARS-CoV-2 variants
por: Taha, Bakr Ahmed, et al.
Publicado: (2023)

Nano-Microparticle Platforms in Developing Next-Generation Vaccines
por: Cappellano, Giuseppe, et al.
Publicado: (2021)

Decoding the next SARS-CoV-2 variant
por: Nel, Jeremy, et al.
Publicado: (2022)

Bacteriophage T4 Vaccine Platform for Next-Generation Influenza Vaccine Development
por: Li, Mengling, et al.
Publicado: (2021)

Broad neutralization against SARS-CoV-2 variants induced by a next-generation protein vaccine V-01
por: Sun, Shiyu, et al.
Publicado: (2021)

Where is the next SARS-CoV-2 variant of concern?
por: Dennehy, John J, et al.
Publicado: (2022)

Biotechnological Innovations and Therapeutic Application of Pediococcus and Lactic Acid Bacteria: The Next-Generation Microorganism
por: Peter, Sunday Bulus, et al.
Publicado: (2022)

Base-calling for next-generation sequencing platforms
por: Ledergerber, Christian, et al.
Publicado: (2011)

An FPGA Platform for Next-Generation Grating Encoders
por: Han, Yaodong, et al.
Publicado: (2020)

SeqVItA: Sequence Variant Identification and Annotation Platform for Next Generation Sequencing Data
por: Dharanipragada, Prashanthi, et al.
Publicado: (2018)

Reliability of genomic variants across different next-generation sequencing platforms and bioinformatic processing pipelines
por: Weißbach, Stephan, et al.
Publicado: (2021)

Adenoviral Vector-Based Vaccine Platforms for Developing the Next Generation of Influenza Vaccines
por: Sayedahmed, Ekramy E., et al.
Publicado: (2020)

A platform for leveraging next generation sequencing for routine microbiology and public health use
por: Rusu, Laura I, et al.
Publicado: (2015)

Next-Generation Vaccines: Nanovaccines in the Fight against SARS-CoV-2 Virus and beyond SARS-CoV-2
por: Mufamadi, Maluta Steven, et al.
Publicado: (2023)

Bacteriophages as Biotechnological Tools
por: Elois, Mariana Alves, et al.
Publicado: (2023)

Comparison of next generation diagnostic systems (NGDS) for the detection of SARS‐CoV‐2
por: Sanchez, Antonio O., et al.
Publicado: (2022)

High throughput SARS-CoV-2 variant analysis using molecular barcodes coupled with next generation sequencing
por: Cohen-Aharonov, Lyora A., et al.
Publicado: (2022)

Evaluation of next generation sequencing approaches for SARS-CoV-2
por: Curini, Valentina, et al.
Publicado: (2023)

A next-generation intranasal trivalent MMS vaccine induces durable and broad protection against SARS-CoV-2 variants of concern
por: Xu, Jiayu, et al.
Publicado: (2023)

Potential next-generation medications for self-administered platforms
por: Chen, Cheng-Han, et al.
Publicado: (2022)

Next Generation Mucosal Vaccine Strategy for Respiratory Pathogens
por: Dotiwala, Farokh, et al.
Publicado: (2023)

A decontamination strategy for resolving SARS-CoV-2 amplicon contamination in a next-generation sequencing laboratory
por: Mwangi, Peter, et al.
Publicado: (2022)

Streptomycetes as platform for biotechnological production processes of drugs
por: Barbuto Ferraiuolo, Simona, et al.
Publicado: (2021)

Biotechnological Fungal Platforms for the Production of Biosynthetic Cannabinoids
por: Kosalková, Katarina, et al.
Publicado: (2023)

An effective screening strategy for deafness in combination with a next-generation sequencing platform: a consecutive analysis
por: Sakuma, Naoko, et al.
Publicado: (2016)

Emerging SARS-CoV-2 variants: Why, how, and what's next?
por: Chen, Yu, et al.
Publicado: (2022)

SARS-CoV-2 and the next generations: which impact on reproductive tissues?
por: Zupin, Luisa, et al.
Publicado: (2020)

Evaluation of EPISEQ SARS-CoV-2 and a Fully Integrated Application to Identify SARS-CoV-2 Variants from Several Next-Generation Sequencing Approaches
por: Mugnier, Nathalie, et al.
Publicado: (2022)

Dynamic SARS-CoV-2 emergence algorithm for rationally-designed logical next-generation vaccines
por: Maison, David P., et al.
Publicado: (2022)

The need for more holistic immune profiling in next-generation SARS-CoV-2 vaccine trials
por: Murphy, Robert L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_oid5r4avjv7k3j4vsmu019uvkj